Navigation Links
Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential

NEEDHAM, Mass.--(BUSINESS WIRE)--May 18, 2007 - AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today positive preliminary results from an investigational double-blind, placebo-controlled Phase 1/2 dose-escalating clinical trial of its typhoid fever vaccine candidate, Ty800, in healthy volunteers. The researchers found the single-dose, oral vaccine to be well tolerated and immunogenic, with over 90% of vaccinated subjects generating immune responses. Based on these excellent results, AVANT plans to further develop Ty800 to compete in the expanding typhoid fever vaccine market, which currently has over $200 million in annual sales. AVANT plans to initiate its own sponsored Phase 2 dose-ranging trial of Ty800 in mid-2007.

"Typhoid fever remains endemic in many developing areas of the world, as well as being an important potential health threat for travelers and military personnel in areas affected by the disease," said Dr. Mitchell B. Cohen, Principal Investigator in the study and Director of Gastroenterology, Hepatology and Nutrition at Cincinnati Children's Hospital Medical Center. "The development of an effective and practical vaccine for all ages will provide an important tool for controlling this disease. A safe typhoid fever vaccine that can be easily administered could significantly reduce the morbidity and mortality associated with typhoid fever."

"We are delighted with these results for our single-dose, oral Ty800 vaccine candidate," said Una S. Ryan, Ph.D., President and Chief Executive Officer of AVANT Immunotherapeutics, Inc. "These results indicate that AVANT's vaccine may have significant potential advantages over the currently licensed vaccines, which offer limited protection rates of 50-80% and require either a single needle injection or three to four oral doses over the course of a week. We believe a more efficacious, easier-to-use typhoid fever vaccine could greatly expand the cur
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
3. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
7. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
8. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
9. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
10. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
11. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
Post Your Comments:
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... the "Medical Oxygen Systems - Global Strategic Business ... report analyzes the worldwide markets for Medical Oxygen Systems ... Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen ... the US, Canada , ...
(Date:4/17/2015)... , April 17, 2015   IBA Molecular, ... radiopharmaceuticals, announced today that it has signed a definitive ... America, Inc. (IBAM NA), to Illinois Health and Science (IHS). ... as an independent company headquartered in Dulles, ... take advantage of new product and footprint synergies. IBA ...
(Date:4/17/2015)... , April 17, 2015 TWi Pharmaceuticals, Inc. ... TWi Pharmaceuticals USA , has obtained ... United States.  It has been in close contact with ... expects to have its own label specialty generic products ... the U.S. pharma market. According to IMS ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... Korea, Nov. 15, 2011 The grand opening ceremony for ... November 10, 2011. RNL BIO ( www.rnl.co.kr ), ... the world,s largest stem cell medical center in Beijing, China. ... "Yanda International Medical Research Institute" (President : Li Hailing, ...
... The new harder to crush version of OxyContin® ... to research revealed at a conference of law enforcement ... and Prevention (CDC) announced that every day 100 people ... involving prescription opioid pain relievers. A new formulation of ...
Cached Medicine Technology:RNL Opens the World's Largest Stem Cell Medical Center in Beijing, China 2New OxyContin® Has Lower Street Price Than Old Crushable Formulation 2
(Date:4/19/2015)... Insurancecarsinsurance.com has released a new blog post making weather ... can affect auto insurance premiums . , ... insurance premiums. In some Northern states like Wisconsin, due ... in other parts. The newly released blog post explains ... months and what impact, if any, it will have ...
(Date:4/19/2015)... McCann Investigations, a Texas-based full services private investigations ... paper Married, but Dating: The Rise of the ... a unique environment of privacy, anonymity and unlimited access, ... spouses has emerged. Social platforms which have been created ... online. Dating sites and mobile apps have found ...
(Date:4/18/2015)... April 19, 2015 For some people, tattoos ... display for the rest of their lives, as they have ... and put in a great amount of thought on their ... they have outgrown them or simply want them removed for ... regret their tattoo, and in 2012-13 there was a 43 ...
(Date:4/18/2015)... April 18, 2015 Carinsurancesavings.biz has released ... plans are cheaper during Spring. , Spring ... insurance plan. Drivers should make sure they compare the ... vehicles. Clients can learn more about Spring car insurance ... , Auto insurance quotes are becoming more and more ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Review of ... hosting a ‘Strategies for Success’ program for cataract surgeons ... meeting in San Diego, where eye surgeon Jeffrey L. ... this invitation-only event. Dr. Martin is the Managing Partner ... of Ophthalmology chose Dr. Martin to lead this year’s ...
Breaking Medicine News(10 mins):Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... DENVER, Feb. 12 The Blue Buffalo ... Connecticut-based,organization dedicated to raising awareness for canine ... to Morris Animal Foundation (MAF) in the,nonprofit,s ... prevent feline cancer.,The Blue Buffalo Foundation has ...
... new low-fat ice cream dipped in chocolate, OAKLAND, ... The Skinny Cow(R) brand urges dieters everywhere to release ... in at just 80 calories per pop, the perfectly-portioned,chocolate-dipped ... and refreshing mint flavors. Skinny Dippers contain no trans ...
... Currently Use Avastin to Treat the Disease, ... Resources, WALTHAM, Mass., Feb. 11 Decision ... advisory firms focusing on,pharmaceutical and healthcare issues, reports ... against Genentech/Roche,s Avastin for,first-line treatment of breast cancer ...
... SAN DIEGO, Feb. 11 SpectraScience, Inc. ... medical devices company, today,announced that it has ... relations consulting firm to provide strategic investor ... of SpectraScience, stated, "We,have selected Hayden Communications ...
... The Office of,Administration today announced it has extended the ... select a new medical plan. The new,plans will become ... health care plan can be difficult, and we,have heard ... their medical options," Secretary of Administration Naomi Wyatt said.,"Therefore, ...
... Feb. 11 AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology ... company,s financial results,for the fourth quarter and full year ended December 31, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), WHEN: ... -- Call ...
Cached Medicine News:Health News:The Blue Buffalo Foundation for Cancer Research Sponsors Six Morris Animal Foundation Cancer Studies 2Health News:Dip Your Diet in Chocolate ... Introducing New Skinny Dippers! 2Health News:Despite Oncologists' Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23 2Health News:SpectraScience, Inc. Retains Hayden Communications 2Health News:Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 2Health News:AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call 2
... second-generation application software for use with the ... release includes a range of new features ... Included are automatic tools to aid diagnosis ... which highlights images that may include blood ...
... (EGG) Analysis for POLYGRAM NET™ works with ... and analyze multichannel EGG signals. The EGG ... preparation by performing an automatic electrode impedance ... the beginning of a recording. If the ...
... Bile Reflux Analysis for POLYGRAM NET® is an ... add-on allows medical professionals to upload and analyze ... reflux recorder. The primary difference is that bile ... a certain wavelength of light corresponding to the ...
Symbia T6, a True Point SPECT·CT system, combines a dual-detector variable angle gamma camera with a six slice CT scanner for advanced oncology, neurology, and cardiology applications....
Medicine Products: